Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2013 1
2015 2
2016 3
2017 6
2018 4
2019 2
2020 5
2021 4
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology.
Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P. Bhalla A, et al. Among authors: kjarsgaard m. Allergy. 2021 Mar;76(3):957-958. doi: 10.1111/all.14534. Epub 2020 Aug 24. Allergy. 2021. PMID: 32767400 Free PMC article. No abstract available.
Airway autoantibodies are determinants of asthma severity.
Salter B, Zhao N, Son K, Suray Tan N, Dvorkin-Gheva A, Radford K, LaVigne N, Huang C, Kjarsgaard M, Li QZ, Tselios K, Fang Lim H MD, Khalidi N, Nair P, Mukherjee M. Salter B, et al. Among authors: kjarsgaard m. Eur Respir J. 2022 Jul 1:2200442. doi: 10.1183/13993003.00442-2022. Online ahead of print. Eur Respir J. 2022. PMID: 35777765
Omalizumab in patients with severe asthma and persistent sputum eosinophilia.
Mukherjee M, Kjarsgaard M, Radford K, Huang C, Leigh R, Dorscheid DR, Lemiere C, Boulet LP, Waserman S, Martin J, Nair P. Mukherjee M, et al. Among authors: kjarsgaard m. Allergy Asthma Clin Immunol. 2019 Apr 3;15:21. doi: 10.1186/s13223-019-0337-2. eCollection 2019. Allergy Asthma Clin Immunol. 2019. PMID: 30988677 Free PMC article.
Sputum autoantibodies in patients with severe eosinophilic asthma.
Mukherjee M, Bulir DC, Radford K, Kjarsgaard M, Huang CM, Jacobsen EA, Ochkur SI, Catuneanu A, Lamothe-Kipnes H, Mahony J, Lee JJ, Lacy P, Nair PK. Mukherjee M, et al. Among authors: kjarsgaard m. J Allergy Clin Immunol. 2018 Apr;141(4):1269-1279. doi: 10.1016/j.jaci.2017.06.033. Epub 2017 Jul 24. J Allergy Clin Immunol. 2018. PMID: 28751233
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms.
Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, Lau KS, Cowbrough B, Radford K, Huang C, Kjarsgaard M, Dvorkin-Gheva A, Smith J, Li QZ, Waserman S, Ryerson CJ, Nair P, Ho T, Balakrishnan N, Nazy I, Bowdish DM, Svenningsen S, Carlsten C, Mukherjee M. Son K, et al. Among authors: kjarsgaard m. Eur Respir J. 2022 Sep 22:2200970. doi: 10.1183/13993003.00970-2022. Online ahead of print. Eur Respir J. 2022. PMID: 36137590
Sputum Antineutrophil Cytoplasmic Antibodies in Serum Antineutrophil Cytoplasmic Antibody-Negative Eosinophilic Granulomatosis with Polyangiitis.
Mukherjee M, Thomas SR, Radford K, Dvorkin-Gheva A, Davydchenko S, Kjarsgaard M, Svenningsen S, Almas S, Felix LC, Stearns J, Li QZ, Khalidi N, Lacy P, Nair PK. Mukherjee M, et al. Among authors: kjarsgaard m. Am J Respir Crit Care Med. 2019 Jan 15;199(2):158-170. doi: 10.1164/rccm.201804-0809OC. Am J Respir Crit Care Med. 2019. PMID: 30179583
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis.
Dasgupta A, Kjarsgaard M, Capaldi D, Radford K, Aleman F, Boylan C, Altman LC, Wight TN, Parraga G, O'Byrne PM, Nair P. Dasgupta A, et al. Among authors: kjarsgaard m. Eur Respir J. 2017 Mar 15;49(3):1602486. doi: 10.1183/13993003.02486-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28298405 Free article. Clinical Trial. No abstract available.
31 results